Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-25-024441
Filing Date
2025-05-12
Accepted
2025-05-12 07:12:43
Documents
4
Effectiveness Date
2025-05-12

Document Format Files

Seq Description Document Type Size
1 S-8 avtx-formsx82025inducement.htm S-8 67480
2 EX-FILING FEES ex-107sx8filingfeetable202.htm EX-FILING FEES 19183
3 EX-5.1 ex-51sx8wyrickopinionconse.htm EX-5.1 7647
4 EX-23.1 ex-231sx8eyconsent2025indu.htm EX-23.1 2237
  Complete submission text file 0001628280-25-024441.txt   97693
Mailing Address 1500 LIBERTY RIDGE DRIVE SUITE 321 WAYNE PA 19087
Business Address 1500 LIBERTY RIDGE DRIVE SUITE 321 WAYNE PA 19087 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-287176 | Film No.: 25932570
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)